There are 43,909 results relating to "who is my msp"
Order by
|
Official Report
Meeting date:
10 November 2004
Public Petitions Committee, 10 Nov 2004
I declare my local interest as the MSP who covers that part of the world.
Official Report
Meeting date:
27 October 1999
Standards Committee, 27 Oct 1999
That approach was accepted as a constituency MSP, not as a minister, and a date was arranged.
Official Report
Meeting date:
4 October 2006
Public Petitions Committee, 04 Oct 2006
A friend of mine, the former MSP Lloyd Quinan, visited Palestine while he was an MSP.
Official Report
Meeting date:
28 March 2006
Standards and Public Appointments Committee, 28 Mar 2006
I suggest that a substantially higher threshold should be set—it would probably have to be as high as 10 per cent of an MSP's salary. I will illustrate why I say that.
Committee reports
Date published:
30 June 2020
Supply and demand for medicines
Roche Products Ltd
Jonathan Burton, Chair, Scottish Pharmacy Board, Royal Pharmaceutical Society in Scotland
Campbell Shimmins - Community Pharmacy Scotland
Healthcare Distribution Association
Claire Fernie - NHS Fife
Correspondence
Letter to Jeane Freeman MSP, Cabinet Secretary for Health and Sport from Lewis Macdonald MSP, Convener of the Health and Sport Committee - 13 December 2019
Letter from Jeane Freeman MSP, Cabinet Secretary for Health and Sport to Lewis Macdonald MSP, Convener of the Health and Sport Committee - 13 January 2020
Letter from Elizabeth Woodeson, Director of Medicines and Pharmacy, Department of Health and Social Care, UK Government to Lewis Macdonald MSP, Convener of the Health and Sport Committee - 24 January 2020
The Convener issued letters seeking further information following the evidence sessions on 21 January 2020:
Letter to Alison Culpan, Scotland Director, Association of the British Pharmaceutical Industry - 5 February 2020
Letter to Warwick Smith, Director General, British Generic Manufacturers Association - 5 February 2020
Letter to Rose Marie Parr, Chief Pharmaceutical Officer, Scottish Government - 5 February 2020
Letter to Matt Barclay, Director of Operations, Community Pharmacy Scotland - 5 February 2020
Letter to Elizabeth Woodeson, Director of Medicines and Pharmacy, Department of Health and Social Care, UK Government - 5 February 2020
Letter to Jonathan Mogford, Director of Policy, Medicines and Healthcare products Regulatory Agency (MHRA) - 5 February 2020
Letter to Lindsay McClure, Associate Director, Medicines Pricing and Supply, NHS National Services Scotland - 5 February 2020
Letter to Dr Alan MacDonald, Chair, Scottish Medicines Consortium - 5 February 2020
Letter to The Rt Hon Priti Patel MP, Secretary of State for the Home Department, Home Office - 6 February 2020
The Convener received the following responses to the above letters:
Letter from Matt Barclay, Director of Operations, Community Pharmacy Scotland - 20 February 2020
Letter from Lindsay McClure, Associate Director, Medicines Pricing and Supply, NHS National Services Scotland - 24 February 2020
Letter from Elizabeth Woodeson, Director of Medicines and Pharmacy, Department of Health and Social Care, UK Government - 26 February 2020
Letter from Alison Culpan, Scotland Director, Association of the British Pharmaceutical Industry - 26 February 2020
Letter from Rose Marie Parr, Chief Pharmaceutical Officer, Scottish Government - 26 February 2020
Letter from Dr Alan MacDonald, Chair, Scottish Medicines Consortium - 26 February 2020
Letter from Warwick Smith, Director General, British Generics Manufacturers Association - 26 February 2020
Letter from the Minister of State for Crime and Policing - 3 March 2020
Letter from Jonathan Mogford, Director of Policy, Medicines and Healthcare products Regulatory Agency (MHRA) - 4 March 2020
The Convener issued letters seeking further information following the evidence sessions on 28 January and 4 February 2020:
Letter to Matt Barclay, Director of Operations, Community Pharmacy Scotland - 17 February 2020
Letter to John Burns, Chief Executive, NHS Ayrshire and Arran - 17 February 2020
Letter to Gail Caldwell, Director of Pharmacy, NHS Greater Glasgow and Clyde - 17 February 2020
Letter to Professor Angela Timoney, Director of Pharmacy, NHS Lothian - 17 February 2020
Letter to David Coulson, Assistant Director of Pharmacy, NHS Tayside - 17 February 2020
Letter to Dr Scott Jamieson, Royal College of General Practitioners - 17 February 2020
Letter to Jonathan Burton, Chair of the Scottish Pharmacy Board, Royal Pharmaceutical Society in Scotland - 17 February 2020
The Convener received the following responses to the above letters:
Letter from Gail Caldwell, Director of Pharmacy, NHS Greater Glasgow and Clyde - 28 February 2020
Letter from David Coulson, Assistant Director of Pharmacy, NHS Tayside - 2 March 2020
Letter from Professor Angela Timoney, Director of Pharmacy, NHS Lothian - 2 March 2020
Letter from Dr Scott Jamieson, Royal College of General Practitioners - 2 March 2020
Letter from Matt Barclay, Director of Operations, Community Pharmacy Scotland - 3 March 2020
Letter from John Burns, Chief Executive, NHS Ayrshire and Arran - 3 March 2020
The Convener issued letters seeking further information following the evidence session on 18 February 2020:
Letter to Dr Sheuli Porkess, Executive Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry - 28 February 2020
Letter to Adam Stachura, Head of Policy and Communications, Age Scotland - 28 February 2020
Letter to Nicola Cotter, Head of GMC Scotland (General Medical Council) - 28 February 2020
Letter to Dr David Shackles, Executive Officer for Interface and Out of Hours, Royal College of General Practitioners - 28 February 2020
Letter to Jonathan Burton, Chair of the Scottish Pharmacy Board, Royal Pharmaceutical Society in Scotland - 28 February 2020
The Convener received the following responses to the above letters:
Letter from Dr Sheuli Porkess, Executive Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry - 4 March 2020
Letter from Nicola Cotter, Head of GMC Scotland (General Medical Council) - 4 March 2020
Letter from Dr David Shackles, Executive Officer for Interface and Out of Hours, Royal College of General Practitioners - 9 March 2020
Letter from Jonathan Burton, Chair of the Scottish Pharmacy Board, Royal Pharmaceutical Society in Scotland - 25 March 2020
Following the Cabinet Secretary for Health and Sport's evidence session on 10 March 2020, the Convener issued a letter seeking further information on a number of points:
Letter to Jeane Freeman MSP, Cabinet Secretary for Health and Sport from Lewis Macdonald MSP, Convener of the Health and Sport Committee - 23 March 2020
Official reports
Tuesday 10 March 2020 - Evidence from the Cabinet Secretary for Health and Sport
Tuesday 18 February 2020 - Evidence from stakeholders
Tuesday 04 February 2020 - Evidence from stakeholders
Tuesday 28 January 2020 - Evidence from stakeholders
Tuesday 21 January 2020 - Evidence from stakeholders
Annexe C
Core and additional pharmacotherapy services Scottish Government (2017).
Official Report
Meeting date:
13 February 2007
Enterprise and Culture Committee, 13 Feb 2007
We are talking about 40 out of 129 MSPs. I do not think that we will do better than that.
Official Report
Meeting date:
11 May 2004
Local Government and Transport Committee, 11 May 2004
Non-committee members are also present today to contribute to the debate and perhaps to move amendments: I welcome Helen Eadie MSP, Elaine Smith MSP and Bill Aitken MSP.
Official Report
Meeting date:
7 October 2003
Procedures Committee, 07 Oct 2003
We decided on those options previously and decided that we would send a focused questionnaire to MSPs to find out their views on the options.
Official Report
Meeting date:
27 February 2001
Public Petitions Committee, 27 Feb 2001
I do not understand how a person who is not employed by an MSP could take the matter to an industrial tribunal.
Official Report
Meeting date:
14 March 2006
Glasgow Airport Rail Link Bill Committee, 14 Mar 2006
However, I want to bring to the committee's attention something of which I have already notified the clerk through my office. At functions that MSPs have been invited to attend, I have sat as a guest at the table of Scottish Airports, which is part of the British Airports Authority, although I do not consider that that impugns my ability to act impartially....
